Atlas Trials

Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)

Clinical trial NCT01176266 · COMPLETED

Trial details

NCT number
NCT01176266
Sponsor
Alexion Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hypophosphatasia
Start date
2010-07-01
Primary completion
2016-09-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.